Minocycline-induced hyperpigmentation in leprosy

British Journal of Dermatology

Volumn 134, Issue 4, 1996, Pages 784-787

  Fleming, C J ^a   Hunt, M J ^a   Salisbury, E L C ^a   Mccarthy, S W ^a   Barnetson, R StC ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE; DAPSONE; MINOCYCLINE; PREDNISOLONE; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; LEPROSY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030001656     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb06992.x     Document Type: Article

References (18)

1. Bryceson ADM. Leprosy. In: Rook, Williamson and Ebling Textbook of Dermatology (Champion WJ, Burton JL, Ebling FJG, eds), 5th edn. Vol. 2. Oxford: Blackwell Scientific Publications. 1992: 1065-84.
2. Mayers WM, Marty AM. Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects. Drugs 1991; 41: 832-56.
3. Gelber RH. Activity of minocycline in Mycobacteria leprae-infected mice. J Infect Dis 1987; 156: 236-9.
4. Pepine M, Flowers FP, Ramos-Caro FA. Extensive cutaneous hyperpigmentation caused by minocycline. J Am Acad Dermatol 1993; 28: 292-5.
5. Basler RSW. Minocycline-related hyperpigmentation. Arch Dermatol 1985; 121: 606-8.
6. Gordon G, Sparano BM, Iatrpoulos MJ. Hyperpigmentation of the skin associated with minocycline therapy. Arch Dermatol 1985; 121: 618-23.
7. Caro I. Discoloration of the teeth related to minocycline therapy for acne. J Am Acad Dermatol 1980; 3: 317-18.
8. Saul HS, Dekker A, Lee RE, Breitfeld V. The black thyroid. Its relation to minocycline use in man. Arch Pathol Lab Med 1983; 107: 173-7.
9. Granstein RD, Sober AJ. Drug- and heavy metal-induced hyperpigmentation. J Am Acad Dermatol 1981; 5: 1-18.
10. Okada N, Moriya K et al. Skin pigmentation associated with minocycline therapy. Br J Dermatol 1989; 121: 247-54.
11. McGrae JD, Zelickson AS. Skin pigmentation secondary to minocycline therapy. Arch Dermatol 1980; 116: 1262-5.
12. Ridgeway HA, Sonnex TS, Kennedy CTC et al. Hyperpigmentation associated with oral minocycline. Br J Dermatol 1980; 107: 95-102.
13. Fenske NA, Millns JL, Greer KE. Minocycline-induced pigmentation at sites of cutaneous inflammation. J Am Med Assoc 1980; 244: 1103-6.
14. Bleehen SS, Gould DJ, Harrington CI et al. Occupational argyria: light and electron microscopic studies and X-ray microanalysis. Br J Dermatol 1981; 104: 19-26.
15. Leonard PA, Moatamed F, Ward JR et al. Chrysiasis; the role of sun exposure in dermal hyperpigmentation secondary to gold therapy. J Rheumatol 1986; 13: 58-64.
16. Dwyer CM, Cuddihy AM, Kerr REI et al. Skin pigmentation due to minocycline treatment of facial dermatoses. Br J Dermatol 1993; 129: 158-62.
17. Job CK, Yodar L, Jacobson RR, Hastings RC. Skin pigmentation from clofazimine therapy in leprosy patients: a reappraisal. J Am Acad Dermatol 1990; 23: 236-41.
18. Fairbanks VF, Beutler E. The thalassaemias. In: Haematology (Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds). 4th edn. New York: McGraw-Hill, 1990: 510-59.